伦丁南通过抑制CAV1/SDHA调节的线粒体功能障碍来缓解糖尿病心肌病
Shuiqing Hu1, Jinlan Luo2, Ping Guo1
1Division of Cardiology and Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan 430030, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|October 7, 2023
概括
伦丁南 (LNT) 通过保护心肌细胞亡和线粒体功能障碍,预防糖尿病心肌病 (DCM). 这种效果是由Lentinan调解的.
科学领域:
- 心血管生物学 心血管生物学
- 线粒体医学 线粒体医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病心肌病 (DCM) 是糖尿病患者死亡的主要原因,与线粒体功能障碍和能量受损有关.
- 在线粒体通路内识别治疗点对于管理DCM至关重要.
- 伦丁南 (LNT) 是一种来自Lentinus edodes的多糖,显示出对代谢综合征调节的潜力.
研究的目的:
- 调查Lentinan (LNT) 对糖尿病心肌病 (DCM) 的药理作用和潜在机制.
- 阐明了Caveolin-1 (CAV1) 和酸脱酶亚单元A (SDHA) 在DCM病原和LNT作用中的作用.
主要方法:
- 在糖尿病db/db小鼠模型中使用LNT.
- 在体内和体外研究涉及CAV1过度表达和沉默.
- 生物信息学分析以确定蛋白质相互作用和无处不在的途径.
- 评估心肌细胞亡,线粒体功能和SDHA蛋白水平.
主要成果:
- 在db/db小鼠中,LNT治疗显著降低了心肌细胞亡,改善了线粒体功能,防止了DCM.
- CAV1过度表达否定了LNT的保护作用,突出了其关键作用.
- 发现CAV1与SDHA结合,促进其无处不在和降解,导致线粒体功能障碍和亡.
- 沉默CAV1改善了线粒体功能,降低了细胞亡,SDHA敲击阻断了这些效应.
结论:
- CAV1与SDHA直接相互作用,导致SDHA降解,线粒体功能障碍和DCM中的亡.
- 使用LNT可以抑制CAV1/SDHA相互作用,从而防止DCM的进展.
- LNT代表了DCM的潜在治疗剂,并且准CAV1/SDHA途径提供了一个有前途的治疗策略.
相关概念视频
01:29Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
445
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
445
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11